Drug Profile
Research programme: enzyme inhibitors - Zensun
Alternative Names: ZS03Latest Information Update: 11 Sep 2023
Price :
$50
*
At a glance
- Originator Zensun (Shanghai) Sci & Tech
- Class Cardiovascular therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cardiomyopathies; Neurological disorders
Most Recent Events
- 11 Sep 2023 Discontinued - Preclinical for Cardiomyopathies in China (unspecified route)
- 11 Sep 2023 Discontinued - Preclinical for Neurological disorders in China (unspecified route)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Cardiomyopathies in China